NPC released its performance for the first three quarters, with a net profit attributable to the parent company of 402 million yuan, a year-on-year decrease of 9.03%
According to the Zhitong Finance APP, NPC disclosed its third-quarter report for 2025. The company achieved a revenue of 41.135 billion yuan in the first three quarters, a year-on-year increase of 0.48%; the net profit attributable to shareholders was 402 million yuan, a year-on-year decrease of 9.03%; the net profit excluding non-recurring gains and losses was 371 million yuan, a year-on-year decrease of 14.78%; the basic earnings per share were 0.31 yuan
According to the Zhitong Finance APP, Nanjing Pharmaceutical (600713.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 41.135 billion yuan in the first three quarters, a year-on-year increase of 0.48%; the net profit attributable to shareholders was 402 million yuan, a year-on-year decrease of 9.03%; the net profit excluding non-recurring items was 371 million yuan, a year-on-year decrease of 14.78%; the basic earnings per share were 0.31 yuan
